Amedisys Q1 revenue up to $571.4M; adjusted EPS $1.03 vs $1.00 YoY

AMEDISYS INC

2024-Q1 EPS reported $0.44 revenue$571,414,000

Net service revenue $571.4M, up $15.0M YoY; prior year included $15M from divested personal care.
GAAP net income $14.4M ($0.44 diluted EPS) vs $25.2M ($0.77) in 2023; includes $20.7M merger expenses.
Adjusted EBITDA $59.9M vs $57.8M; adjusted net income $33.9M ($1.03 diluted EPS) vs $32.7M ($1.00).

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

AMEDISYS INC reported three-month period ended March 31, 2024 results: revenue Net service revenue increased $15.0 million to $571.4 million compared to $556.4 million in 2023., net income Net income attributable to Amedisys, Inc. of $14.4 million, EPS Net income attributable to Amedisys, Inc. per diluted share of $0.44 compared to $0.77 in 2023..

Period: three-month period ended March 31, 2024
Revenue: Net service revenue increased $15.0 million to $571.4 million compared to $556.4 million in 2023.
Net income: Net income attributable to Amedisys, Inc. of $14.4 million
EPS: Net income attributable to Amedisys, Inc. per diluted share of $0.44 compared to $0.77 in 2023.
Result: reported results

Exact text from the filing

On April 24, 2024, Amedisys, Inc. ("we," "us," "our," or "the Company") issued a press release (the “Press Release”) announcing its financial results for the three-month period ended March 31, 2024.

View on SEC.gov

Browse all earnings releases →

Source: SEC EDGAR

accession 0000896262-24-000018

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.